NABILAHMEDNABIL AHMED0.000000000000000.00000000000000613AHMED, NABILProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:orcidIdORCID idvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25082406Hegde M, Moll AJ, Byrd TT, Louis CU, Ahmed NCytotherapyCellular immunotherapy for pediatric solid tumors. Cytotherapy. 2015 Jan; 17(1):3-17.Cytotherapy2014-07-28T00:00:002014Cellular immunotherapy for pediatric solid tumors.Authorship 859351Authorship 1041411Authorship 158538525800760Ahmed N, Brawley VS, Hegde M, Robertson C, Ghazi A, Gerken C, Liu E, Dakhova O, Ashoori A, Corder A, Gray T, Wu MF, Liu H, Hicks J, Rainusso N, Dotti G, Mei Z, Grilley B, Gee A, Rooney CM, Brenner MK, Heslop HE, Wels WS, Wang LL, Anderson P, Gottschalk SJournal of clinical oncology : official journal of the American Society of Clinical OncologyHuman Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma. J Clin Oncol. 2015 May 20; 33(15):1688-96.J Clin Oncol2015-03-23T00:00:002015Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma.Authorship 161147325505736Landi D, Hegde M, Ahmed NFrontiers in oncologyHuman cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapy. Front Oncol. 2014; 4:338.Front Oncol2014-11-26T00:00:002014Human cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapy.Authorship 289031Authorship 1631191MD AndersonAMY BHEIMBERGERAMY B HEIMBERGER9035HEIMBERGER, AMY BProfessorAuthorship 459125Authorship 632541Authorship 716251Authorship 2965582Authorship 2971716Authorship 2998441424773122O'Reilly M, Federoff HJ, Fong Y, Kohn DB, Patterson AP, Ahmed N, Asokan A, Boye SE, Crystal RG, De Oliveira S, Gargiulo L, Harper SQ, Ikeda Y, Jambou R, Montgomery M, Prograis L, Rosenthal E, Sterman DH, Vandenberghe LH, Zoloth L, Abedi M, Adair J, Adusumilli PS, Goins WF, Gray J, Monahan P, Popplewell L, Sena-Esteves M, Tannous B, Weber T, Wierda W, Gopal-Srivastava R, McDonald CL, Rosenblum D, Corrigan-Curay JHuman gene therapyGene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013. Hum Gene Ther. 2014 Jun; 25(6):488-97.Hum Gene Ther2014-06-01T00:00:002014Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013.26202733Byrd T, Carr KD, Norman JC, Huye L, Hegde M, Ahmed NCytometry. Part A : the journal of the International Society for Analytical CytologyPolystyrene microspheres enable 10-color compensation for immunophenotyping of primary human leukocytes. Cytometry A. 2015 Nov; 87(11):1038-46.Cytometry A2015-07-22T00:00:002015Polystyrene microspheres enable 10-color compensation for immunophenotyping of primary human leukocytes.26240290Fousek K, Ahmed NClinical cancer research : an official journal of the American Association for Cancer ResearchThe Evolution of T-cell Therapies for Solid Malignancies. Clin Cancer Res. 2015 Aug 01; 21(15):3384-92.Clin Cancer Res2015-08-01T00:00:002015The Evolution of T-cell Therapies for Solid Malignancies.26341370Wakefield A, Pignata A, Ghazi A, Ashoori A, Hegde M, Landi D, Gray T, Scheurer ME, Chintagumpala M, Adesina A, Gottschalk S, Hicks J, Powell SZ, Ahmed NJournal of neuro-oncologyIs CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients. J Neurooncol. 2015 Nov; 125(2):307-15.J Neurooncol2015-09-04T00:00:002015Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.74Professor10Assistant Professor14Associate Professor42Director6Adjunct Professor47Distinguished Service Professor27427982Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed NThe Journal of clinical investigationTandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape. J Clin Invest. 2016 08 01; 126(8):3036-52.J Clin Invest2016-07-18T00:00:002016Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape.Authorship 321764227068945Navai SA, Ahmed NBiochemical Society transactionsTargeting the tumour profile using broad spectrum chimaeric antigen receptor T-cells. Biochem Soc Trans. 2016 Apr 15; 44(2):391-6.Biochem Soc Trans2016-04-15T00:00:002016Targeting the tumour profile using broad spectrum chimaeric antigen receptor T-cells.20307713Ahmed N, Heslop HE, Mackall CLPediatric clinics of North AmericaT-cell-based therapies for malignancy and infection in childhood. Pediatr Clin North Am. 2010 Feb; 57(1):83-96.Pediatr Clin North Am2010-02-01T00:00:002010T-cell-based therapies for malignancy and infection in childhood.1102 BATESHouston, 77030TX16755222Ahmed N, Heslop HECurrent opinion in hematologyViral lymphomagenesis. Curr Opin Hematol. 2006 Jul; 13(4):254-9.Curr Opin Hematol2006-07-01T00:00:002006Viral lymphomagenesis.17198088Leen A, Ratnayake M, Foster A, Heym K, Ahmed N, Rooney CM, Gottschalk SJournal of immunotherapy (Hagerstown, Md. : 1997)Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cells. J Immunother. 2007 Jan; 30(1):96-107.J Immunother2007-01-01T00:00:002007Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cells.17575166Ahmed N, Ratnayake M, Savoldo B, Perlaky L, Dotti G, Wels WS, Bhattacharjee MB, Gilbertson RJ, Shine HD, Weiss HL, Rooney CM, Heslop HE, Gottschalk SCancer researchRegression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res. 2007 Jun 15; 67(12):5957-64.Cancer Res2007-06-15T00:00:002007Regression of experimental medulloblastoma following transfer of HER2-specific T cells.17921856Ahmed N, Chizhevsky VJournal of pediatric hematology/oncologyAcute hepatic sequestration associated with pneumococcal infection in a 5-year-old Boy with sickle beta degrees -thalassemia: a case report and review of the literature. J Pediatr Hematol Oncol. 2007 Oct; 29(10):720-4.J Pediatr Hematol Oncol2007-10-01T00:00:002007Acute hepatic sequestration associated with pneumococcal infection in a 5-year-old Boy with sickle beta degrees -thalassemia: a case report and review of the literature.18940685Ahmed N, Leung KS, Rosenblatt H, Bollard CM, Gottschalk S, Myers GD, Carrum G, Heslop HE, Brenner MK, Krance RABiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow TransplantationSuccessful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine. Biol Blood Marrow Transplant. 2008 Nov; 14(11):1298-304.Biol Blood Marrow Transplant2008-11-01T00:00:002008Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.19532139Ahmed N, Salsman VS, Yvon E, Louis CU, Perlaky L, Wels WS, Dishop MK, Kleinerman EE, Pule M, Rooney CM, Heslop HE, Gottschalk SMolecular therapy : the journal of the American Society of Gene TherapyImmunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression. Mol Ther. 2009 Oct; 17(10):1779-87.Mol Ther2009-06-16T00:00:002009Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.19397411Ahmed N, Gottschalk SExpert review of vaccinesHow to design effective vaccines: lessons from an old success story. Expert Rev Vaccines. 2009 May; 8(5):543-6.Expert Rev Vaccines2009-05-01T00:00:002009How to design effective vaccines: lessons from an old success story.20068073Ahmed N, Salsman VS, Kew Y, Shaffer D, Powell S, Zhang YJ, Grossman RG, Heslop HE, Gottschalk SClinical cancer research : an official journal of the American Association for Cancer ResearchHER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors. Clin Cancer Res. 2010 Jan 15; 16(2):474-85.Clin Cancer Res2010-01-12T00:00:002010HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.28166219John Lin CC, Yu K, Hatcher A, Huang TW, Lee HK, Carlson J, Weston MC, Chen F, Zhang Y, Zhu W, Mohila CA, Ahmed N, Patel AJ, Arenkiel BR, Noebels JL, Creighton CJ, Deneen BNature neuroscienceIdentification of diverse astrocyte populations and their malignant analogs. Nat Neurosci. 2017 Mar; 20(3):396-405.Nat Neurosci2017-02-06T00:00:002017Identification of diverse astrocyte populations and their malignant analogs.Authorship 7291961221647415Salsman VS, Chow KK, Shaffer DR, Kadikoy H, Li XN, Gerken C, Perlaky L, Metelitsa LS, Gao X, Bhattacharjee M, Hirschi K, Heslop HE, Gottschalk S, Ahmed NPloS oneCrosstalk between medulloblastoma cells and endothelium triggers a strong chemotactic signal recruiting T lymphocytes to the tumor microenvironment. PLoS One. 2011; 6(5):e20267.PLoS One2011-05-27T00:00:002011Crosstalk between medulloblastoma cells and endothelium triggers a strong chemotactic signal recruiting T lymphocytes to the tumor microenvironment.22742590Byrd T, Grossman RG, Ahmed NPediatric hematology and oncologyMedulloblastoma-biology and microenvironment: a review. Pediatr Hematol Oncol. 2012 Sep; 29(6):495-506.Pediatr Hematol Oncol2012-06-28T00:00:002012Medulloblastoma-biology and microenvironment: a review.23070117Chow KK, Naik S, Kakarla S, Brawley VS, Shaffer DR, Yi Z, Rainusso N, Wu MF, Liu H, Kew Y, Grossman RG, Powell S, Lee D, Ahmed N, Gottschalk SMolecular therapy : the journal of the American Society of Gene TherapyT cells redirected to EphA2 for the immunotherapy of glioblastoma. Mol Ther. 2013 Mar; 21(3):629-37.Mol Ther2012-10-16T00:00:002012T cells redirected to EphA2 for the immunotherapy of glioblastoma.21772253Nakazawa Y, Huye LE, Salsman VS, Leen AM, Ahmed N, Rollins L, Dotti G, Gottschalk SM, Wilson MH, Rooney CMMolecular therapy : the journal of the American Society of Gene TherapyPiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor. Mol Ther. 2011 Dec; 19(12):2133-43.Mol Ther2011-07-19T00:00:002011PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor.22306904Ghazi A, Ashoori A, Hanley PJ, Brawley VS, Shaffer DR, Kew Y, Powell SZ, Grossman R, Grada Z, Scheurer ME, Hegde M, Leen AM, Bollard CM, Rooney CM, Heslop HE, Gottschalk S, Ahmed NJournal of immunotherapy (Hagerstown, Md. : 1997)Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma. J Immunother. 2012 Feb-Mar; 35(2):159-68.J Immunother2012-02-01T00:00:002012Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.28426845Ahmed N, Brawley V, Hegde M, Bielamowicz K, Kalra M, Landi D, Robertson C, Gray TL, Diouf O, Wakefield A, Ghazi A, Gerken C, Yi Z, Ashoori A, Wu MF, Liu H, Rooney C, Dotti G, Gee A, Su J, Kew Y, Baskin D, Zhang YJ, New P, Grilley B, Stojakovic M, Hicks J, Powell SZ, Brenner MK, Heslop HE, Grossman R, Wels WS, Gottschalk SJAMA oncologyHER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial. JAMA Oncol. 2017 Aug 01; 3(8):1094-1101.JAMA Oncol2017-08-01T00:00:002017HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.28663103Mukherjee M, Mace EM, Carisey AF, Ahmed N, Orange JSMolecular therapy : the journal of the American Society of Gene TherapyQuantitative Imaging Approaches to Study the CAR Immunological Synapse. Mol Ther. 2017 08 02; 25(8):1757-1768.Mol Ther2017-06-26T00:00:002017Quantitative Imaging Approaches to Study the CAR Immunological Synapse.Authorship 8747334Authorship 877046129016929Bielamowicz K, Fousek K, Byrd TT, Samaha H, Mukherjee M, Aware N, Wu MF, Orange JS, Sumazin P, Man TK, Joseph SK, Hegde M, Ahmed NNeuro-oncologyTrivalent CAR T cells overcome interpatient antigenic variability in glioblastoma. Neuro Oncol. 2018 03 27; 20(4):506-518.Neuro Oncol2018-03-27T00:00:002018Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma.20686618Fu X, Tao L, Rivera A, Williamson S, Song XT, Ahmed N, Zhang XPloS oneA simple and sensitive method for measuring tumor-specific T cell cytotoxicity. PLoS One. 2010 Jul 29; 5(7):e11867.PLoS One2010-07-29T00:00:002010A simple and sensitive method for measuring tumor-specific T cell cytotoxicity.21110217Day ES, Thompson PA, Zhang L, Lewinski NA, Ahmed N, Drezek RA, Blaney SM, West JLJournal of neuro-oncologyNanoshell-mediated photothermal therapy improves survival in a murine glioma model. J Neurooncol. 2011 Aug; 104(1):55-63.J Neurooncol2010-11-26T00:00:002010Nanoshell-mediated photothermal therapy improves survival in a murine glioma model.Authorship 88242617Authorship 8829707Authorship 88371113Authorship 88489823Authorship 8849401529183891Byrd TT, Fousek K, Pignata A, Szot C, Samaha H, Seaman S, Dobrolecki L, Salsman VS, Oo HZ, Bielamowicz K, Landi D, Rainusso N, Hicks J, Powell S, Baker ML, Wels WS, Koch J, Sorensen PH, Deneen B, Ellis MJ, Lewis MT, Hegde M, Fletcher BS, St Croix B, Ahmed NCancer researchTEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer. Cancer Res. 2018 01 15; 78(2):489-500.Cancer Res2017-11-28T00:00:002017TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.29550628Yanir AD, Martinez CA, Sasa G, Leung K, Gottschalk S, Omer B, Ahmed N, Hegde M, Eunji J, Liu H, Heslop HE, Brenner MK, Krance RA, Naik SBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow TransplantationCurrent Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives-A Single-Center Experience, 2008 to 2016. Biol Blood Marrow Transplant. 2018 07; 24(7):1424-1431.Biol Blood Marrow Transplant2018-03-14T00:00:002018Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives-A Single-Center Experience, 2008 to 2016.29196075Ngwube A, Hanson IC, Orange J, Rider NL, Seeborg F, Shearer W, Noroski L, Nicholas S, Forbes L, Leung K, Sasa G, Naik S, Hegde M, Omer B, Ahmed N, Allen C, Gottschalk S, Wu MF, Liu H, Brenner M, Heslop H, Krance R, Martinez CBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow TransplantationOutcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome. Biol Blood Marrow Transplant. 2018 03; 24(3):537-541.Biol Blood Marrow Transplant2017-11-28T00:00:002017Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome.29630926Yanir AD, Hanson IC, Shearer WT, Noroski LM, Forbes LR, Seeborg FO, Nicholas S, Chinn I, Orange JS, Rider NL, Leung KS, Naik S, Carrum G, Sasa G, Hegde M, Omer BA, Ahmed N, Allen CE, Khaled Y, Wu MF, Liu H, Gottschalk SM, Heslop HE, Brenner MK, Krance RA, Martinez CABiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow TransplantationHigh Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease. Biol Blood Marrow Transplant. 2018 08; 24(8):1643-1650.Biol Blood Marrow Transplant2018-04-06T00:00:002018High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease.true1Associate ProfessorAssociate Professor29624648McClain KL, Picarsic J, Chakraborty R, Zinn D, Lin H, Abhyankar H, Scull B, Shih A, Lim KPH, Eckstein O, Lubega J, Peters TL, Olea W, Burke T, Ahmed N, Hicks MJ, Tran B, Jones J, Dauser R, Jeng M, Baiocchi R, Schiff D, Goldman S, Heym KM, Wilson H, Carcamo B, Kumar A, Rodriguez-Galindo C, Whipple NS, Campbell P, Murdoch G, Kofler J, Heales S, Malone M, Woltjer R, Quinn JF, Orchard P, Kruer MC, Jaffe R, Manz MG, Lira SA, Parsons DW, Merad M, Man TK, Allen CECancerCNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions. Cancer. 2018 06 15; 124(12):2607-2620.Cancer2018-04-06T00:00:002018CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.D011948Chemicals & Drugs36211400.611886Receptors, Antigen, T-CellD018719Chemicals & Drugs51925130.4861Receptor, ErbB-223891738Liu D, Song L, Brawley VS, Robison N, Wei J, Gao X, Tian G, Margol A, Ahmed N, Asgharzadeh S, Metelitsa LSClinical immunology (Orlando, Fla.)Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells. Clin Immunol. 2013 Oct; 149(1):55-64.Clin Immunol2013-06-18T00:00:002013Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells.D053663Chemicals & Drugs16320.959303Interleukin-13 Receptor alpha2 SubunitD005909Disorders40318030.447986GlioblastomaD013601Anatomy82238330.393288T-LymphocytesNeurosurgeryDepartment of PediatricsPediatrics-Hem/Onc Cell & Gene ThePediatrics-Hematology & OncologyBaylor College of MedicineCARIDADMARTINEZCARIDAD MARTINEZ0.000000000000000.000000000000001408MARTINEZ, CARIDADAssociate ProfessorROBERTKRANCEROBERT KRANCE0.000000000000000.000000000000003557KRANCE, ROBERTProfessorMALCOLMBRENNERMALCOLM BRENNER0.000000000000000.000000000000003564BRENNER, MALCOLMDistinguished Service ProfessorCLIONAROONEYCLIONA ROONEY0.000000000000000.000000000000003578ROONEY, CLIONAProfessorADRIANGEEADRIAN GEE0.000000000000000.000000000000003642GEE, ADRIANProfessorANNLEENANN LEEN0.000000000000000.00000000000000435LEEN, ANNProfessor3.01130.00893906310research areas5.277540.024798475coauthor of96.001817.023259similar to1164selected publicationsHELENHESLOPHELEN HESLOP0.000000000000000.000000000000003566HESLOP, HELENProfessorMEENAKSHIHEGDEMEENAKSHI HEGDE29.70731730000000-95.402264500000004493HEGDE, MEENAKSHIAssociate ProfessorSTEPHENGOTTSCHALKSTEPHEN GOTTSCHALK0.000000000000000.0000000000000053GOTTSCHALK, STEPHENAdjunct ProfessorAuthorship 94378415Authorship 943788429788442Joseph SK, Samaha H, Bielamowicz K, Ahmed NNeuro-oncologyResponse to the comment on "Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma" by Bielamowicz et al. Neuro Oncol. 2018 06 18; 20(7):1004-1005.Neuro Oncol2018-06-18T00:00:002018Response to the comment on "Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma" by Bielamowicz et al.Authorship 1268919Authorship 12708614Authorship 1277241023839099Grada Z, Hegde M, Byrd T, Shaffer DR, Ghazi A, Brawley VS, Corder A, Sch?nfeld K, Koch J, Dotti G, Heslop HE, Gottschalk S, Wels WS, Baker ML, Ahmed NMolecular therapy. Nucleic acidsTanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy. Mol Ther Nucleic Acids. 2013 Jul 09; 2:e105.Mol Ther Nucleic Acids2013-07-09T00:00:002013TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy.23946414Glasgow SM, Laug D, Brawley VS, Zhang Z, Corder A, Yin Z, Wong ST, Li XN, Foster AE, Ahmed N, Deneen BThe Journal of neuroscience : the official journal of the Society for NeuroscienceThe miR-223/nuclear factor I-A axis regulates glial precursor proliferation and tumorigenesis in the CNS. J Neurosci. 2013 Aug 14; 33(33):13560-8.J Neurosci2013-08-14T00:00:002013The miR-223/nuclear factor I-A axis regulates glial precursor proliferation and tumorigenesis in the CNS.true1ProfessorProfessor31264975Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed NThe Journal of clinical investigationTandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape. J Clin Invest. 2019 Jul 02; 129(8):3464.J Clin Invest2019-07-02T00:00:002019Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape.true1ProfessorProfessortrue1Distinguished Service ProfessorDistinguished Service Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorAuthorship 9787395Authorship 9802352432205861Fousek K, Watanabe J, Joseph SK, George A, An X, Byrd TT, Morris JS, Luong A, Mart?nez-Paniagua MA, Sanber K, Navai SA, Gad AZ, Salsman VS, Mathew PR, Kim HN, Wagner DL, Brunetti L, Jang A, Baker ML, Varadarajan N, Hegde M, Kim YM, Heisterkamp N, Abdel-Azim H, Ahmed NLeukemiaCAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression. Leukemia. 2021 01; 35(1):75-89.Leukemia2020-03-24T00:00:002020CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression.27601331Gad AZ, El-Naggar S, Ahmed NCytotherapyRealism and pragmatism in developing an effective chimeric antigen receptor T-cell product for solid cancers. Cytotherapy. 2016 11; 18(11):1382-1392.Cytotherapy2016-09-02T00:00:002016Realism and pragmatism in developing an effective chimeric antigen receptor T-cell product for solid cancers.Authorship 9817842Authorship 9819228Authorship 9826615Authorship 98363421Authorship 9836493Authorship 9837789Authorship 9841535Authorship 98434621Authorship 9853156Authorship 9854213Authorship 985810419896544Gardner SL, Ahmed N, Okada HBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow TransplantationImmunotherapy for pediatric central nervous system tumors. Biol Blood Marrow Transplant. 2010 Jan; 16(1 Suppl):S75-81.Biol Blood Marrow Transplant2009-11-05T00:00:002009Immunotherapy for pediatric central nervous system tumors.20855883Hoa N, Ge L, Kuznetsov Y, McPherson A, Cornforth AN, Pham JT, Myers MP, Ahmed N, Salsman VS, Lamb LS, Bowersock JE, Hu Y, Zhou YH, Jadus MRJournal of immunology (Baltimore, Md. : 1950)Glioma cells display complex cell surface topographies that resist the actions of cytolytic effector lymphocytes. J Immunol. 2010 Oct 15; 185(8):4793-803.J Immunol2010-09-20T00:00:002010Glioma cells display complex cell surface topographies that resist the actions of cytolytic effector lymphocytes.26065474Samaha H, El Naggar S, Ahmed NImmunotherapyArmed hunter killers: discerning the role of adoptive T-cell transfer for glioblastoma. Immunotherapy. 2015; 7(5):481-5.Immunotherapy2015-01-01T00:00:002015Armed hunter killers: discerning the role of adoptive T-cell transfer for glioblastoma.28808307Nassar M, Samaha H, Ghabriel M, Yehia M, Taha H, Salem S, Shaaban K, Omar M, Ahmed N, El-Naggar SScientific reportsLC3A Silencing Hinders Aggresome Vimentin Cage Clearance in Primary Choroid Plexus Carcinoma. Sci Rep. 2017 08 14; 7(1):8022.Sci Rep2017-08-14T00:00:002017LC3A Silencing Hinders Aggresome Vimentin Cage Clearance in Primary Choroid Plexus Carcinoma.31504801Foster JB, Madsen PJ, Hegde M, Ahmed N, Cole KA, Maris JM, Resnick AC, Storm PB, Waanders AJNeuro-oncologyImmunotherapy for pediatric brain tumors: past and present. Neuro Oncol. 2019 10 09; 21(10):1226-1238.Neuro Oncol2019-10-09T00:00:002019Immunotherapy for pediatric brain tumors: past and present.Authorship 9881965532341580Donovan LK, Delaidelli A, Joseph SK, Bielamowicz K, Fousek K, Holgado BL, Manno A, Srikanthan D, Gad AZ, Van Ommeren R, Przelicki D, Richman C, Ramaswamy V, Daniels C, Pallota JG, Douglas T, Joynt ACM, Haapasalo J, Nor C, Vladoiu MC, Kuzan-Fischer CM, Garzia L, Mack SC, Varadharajan S, Baker ML, Hendrikse L, Ly M, Kharas K, Balin P, Wu X, Qin L, Huang N, Stucklin AG, Morrissy AS, Cavalli FMG, Luu B, Suarez R, De Antonellis P, Michealraj A, Rastan A, Hegde M, Komosa M, Sirbu O, Kumar SA, Abdullaev Z, Faria CC, Yip S, Hukin J, Tabori U, Hawkins C, Aldape K, Daugaard M, Maris JM, Sorensen PH, Ahmed N, Taylor MDNature medicineLocoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma. Nat Med. 2020 05; 26(5):720-731.Nat Med2020-04-27T00:00:002020Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma.23939024Hegde M, Corder A, Chow KK, Mukherjee M, Ashoori A, Kew Y, Zhang YJ, Baskin DS, Merchant FA, Brawley VS, Byrd TT, Krebs S, Wu MF, Liu H, Heslop HE, Gottschalk S, Gottachalk S, Yvon E, Ahmed NMolecular therapy : the journal of the American Society of Gene TherapyCombinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma. Mol Ther. 2013 Nov; 21(11):2087-101.Mol Ther2013-08-13T00:00:002013Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.Authorship 9944492532669548Hegde M, Joseph SK, Pashankar F, DeRenzo C, Sanber K, Navai S, Byrd TT, Hicks J, Xu ML, Gerken C, Kalra M, Robertson C, Zhang H, Shree A, Mehta B, Dakhova O, Salsman VS, Grilley B, Gee A, Dotti G, Heslop HE, Brenner MK, Wels WS, Gottschalk S, Ahmed NNature communicationsTumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma. Nat Commun. 2020 07 15; 11(1):3549.Nat Commun2020-07-15T00:00:002020Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma.SUJITHJOSEPHSUJITH JOSEPH16259JOSEPH, SUJITH0000-0003-4596-1270Assistant ProfessorAuthorship 1006885933318876Youness RA, Gad AZ, Sanber K, Ahn YJ, Lee GJ, Khallaf E, Hafez HM, Motaal AA, Ahmed N, Gad MZJournal of advanced researchTargeting hydrogen sulphide signaling in breast cancer. J Adv Res. 2021 Jan; 27:177-190.J Adv Res2020-07-16T00:00:002020Targeting hydrogen sulphide signaling in breast cancer.Authorship 1012339233633361Wagner DL, Fritsche E, Pulsipher MA, Ahmed N, Hamieh M, Hegde M, Ruella M, Savoldo B, Shah NN, Turtle CJ, Wayne AS, Abou-El-Enein MNature reviews. Clinical oncologyImmunogenicity of CAR T cells in cancer therapy. Nat Rev Clin Oncol. 2021 06; 18(6):379-393.Nat Rev Clin Oncol2021-02-25T00:00:002021Immunogenicity of CAR T cells in cancer therapy.true1Assistant ProfessorAssistant ProfessorAuthorship 10177621833952672Konduri V, Joseph SK, Byrd TT, Nawas Z, Vazquez-Perez J, Hofferek CJ, Halpert MM, Liu D, Liang Z, Baig Y, Salsman VS, Oyewole-Said D, Tsimelzon A, Burns BA, Chen C, Levitt JM, Yao Q, Ahmed NM, Hegde M, Decker WKScience translational medicineA subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma. Sci Transl Med. 2021 05 05; 13(592).Sci Transl Med2021-05-05T00:00:002021A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma.Authorship 10195175534045740Donovan LK, Delaidelli A, Joseph SK, Bielamowicz K, Fousek K, Holgado BL, Manno A, Srikanthan D, Gad AZ, Van Ommeren R, Przelicki D, Richman C, Ramaswamy V, Daniels C, Pallota JG, Douglas T, Joynt ACM, Haapasalo J, Nor C, Vladoiu MC, Kuzan-Fischer CM, Garzia L, Mack SC, Varadharajan S, Baker ML, Hendrikse L, Ly M, Kharas K, Balin P, Wu X, Qin L, Huang N, Stucklin AG, Morrissy AS, Cavalli FMG, Luu B, Suarez R, De Antonellis P, Michealraj A, Rastan A, Hegde M, Komosa M, Sirbu O, Kumar SA, Abdullaev Z, Faria CC, Yip S, Hukin J, Tabori U, Hawkins C, Aldape K, Daugaard M, Maris JM, Sorensen PH, Ahmed N, Taylor MDNature medicineAuthor Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma. Nat Med. 2021 Jun; 27(6):1117-1120.Nat Med2021-06-01T00:00:002021Author Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma.Authorship 10242492134196303Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed NThe Journal of clinical investigationTandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape. J Clin Invest. 2021 07 01; 131(13).J Clin Invest2021-07-01T00:00:002021Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape.true1ProfessorProfessorAuthorship 144391Authorship 1038759535325065Steffin DHM, Muhsen IN, Hill LC, Ramos CA, Ahmed N, Hegde M, Wang T, Wu M, Gottschalk S, Whittle SB, Lulla PD, Mamonkin M, Omer B, Rouce RH, Heczey A, Metelitsa LS, Grilley BJ, Robertson C, Torrano V, Lapteva N, Gee AP, Rooney CM, Brenner MK, Heslop HEBloodLong-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24.Blood2022-07-07T00:00:002022Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.Authorship 1375113Authorship 1376491924273748Bielamowicz K, Khawja S, Ahmed NFrontiers in oncologyAdoptive cell therapies for glioblastoma. Front Oncol. 2013; 3:275.Front Oncol2013-11-11T00:00:002013Adoptive cell therapies for glioblastoma.true1Associate ProfessorAssociate Professor36453638Martinez C, Aguayo-Hiraldo P, Chaimowitz N, Forbes L, Rider N, Nicholas S, Seeborg F, Chinen J, Chinn I, Davis C, Roseblatt H, Noroski L, Omer B, John T, Yassine K, Naik S, Craddock J, Bhar S, Allen C, Ahmed N, Sasa G, Steffin D, Doherty E, George A, Salem B, Friend B, Hegde M, Brenner MK, Heslop HE, Leen A, Pe?a A, Wu M, Hanson IC, Krance RABlood advancesCord blood transplantation for nonmalignant disorders: early functional immunity and high survival. Blood Adv. 2023 05 09; 7(9):1823-1830.Blood Adv2023-05-09T00:00:002023Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival.Authorship 106143220Authorship 10661163Authorship 1066114335182895Samy W, El Gebaly A, Ahmed NH, Talaat ACytokineGhrelin polymorphism/TRPV1 receptor expression in Egyptian IBS patients. Cytokine. 2022 04; 152:155827.Cytokine2022-02-16T00:00:002022Ghrelin polymorphism/TRPV1 receptor expression in Egyptian IBS patients.31495236Esawy MM, Shabana MA, Ahmed NHScandinavian journal of clinical and laboratory investigationEffect of sample type and storage conditions on Golgi membrane protein 73 stability. Scand J Clin Lab Invest. 2019 Nov; 79(7):491-495.Scand J Clin Lab Invest2019-09-08T00:00:002019Effect of sample type and storage conditions on Golgi membrane protein 73 stability.true1Adjunct ProfessorAdjunct ProfessorAuthorship 10729811237415222Zhang H, Du Y, Qi L, Xiao S, Braun FK, Kogiso M, Huang Y, Huang F, Abdallah A, Suarez M, Karthick S, Ahmed NM, Salsman VS, Baxter PA, Su JM, Brat DJ, Hellenbeck PL, Teo WY, Patel AJ, Li XNJournal of translational medicineTargeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models. J Transl Med. 2023 07 06; 21(1):444.J Transl Med2023-07-06T00:00:002023Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models.true1ProfessorProfessorAuthorship 268016Authorship 228003Authorship 142632324641957Hegde M, Bielamowicz KJ, Ahmed NDiscovery medicineNovel approaches and mechanisms of immunotherapy for glioblastoma. Discov Med. 2014 Mar; 17(93):145-54.Discov Med2014-03-01T00:00:002014Novel approaches and mechanisms of immunotherapy for glioblastoma.24792645Mukherjee M, Byrd T, Brawley VS, Bielamowicz K, Li XN, Merchant F, Maitra S, Sumazin P, Fuller G, Kew Y, Sun D, Powell SZ, Ahmed N, Zhang N, Pati DJournal of neuro-oncologyOverexpression and constitutive nuclear localization of cohesin protease Separase protein correlates with high incidence of relapse and reduced overall survival in glioblastoma multiforme. J Neurooncol. 2014 Aug; 119(1):27-35.J Neurooncol2014-05-04T00:00:002014Overexpression and constitutive nuclear localization of cohesin protease Separase protein correlates with high incidence of relapse and reduced overall survival in glioblastoma multiforme.Authorship 3495614Authorship 149176724841514Krebs S, Chow KK, Yi Z, Rodriguez-Cruz T, Hegde M, Gerken C, Ahmed N, Gottschalk SCytotherapyT cells redirected to interleukin-13Ra2 with interleukin-13 mutein--chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Ra1. Cytotherapy. 2014 Aug; 16(8):1121-31.Cytotherapy2014-05-16T00:00:002014T cells redirected to interleukin-13Ra2 with interleukin-13 mutein--chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Ra1.24876563Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, Grupp SA, Mackall CLBloodCurrent concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014 Jul 10; 124(2):188-95.Blood2014-05-29T00:00:002014Current concepts in the diagnosis and management of cytokine release syndrome.Authorship 14922613Authorship 545814Authorship 641041Authorship 6611217Authorship 736111